Market Cap
$1.8B
XRAY
DENTSPLY SIRONA Inc.
$8.63 ▼ -1.32%
Prev close $8.74Market cap$1.8B
ConsensusSell
12-mo target$13.73 (+59.2%)
▼ Bearish
Analyst conviction 4/10
Insider Buying Cluster (2 insiders)35 New Institutional Positions15 Institutional Exits Healthcare & Medical Devices
Snapshot
The big-picture read on XRAY right now — valuation, ownership and activity at a glance.
Cap Size
Small Cap
Analyst Consensus
Hold (35%)
Inst. Holders
50 funds
Inst. Value
$1.7B
Inst. Activity
35 buys / 15 sells
Insider Activity
$1.2M buy / $0.00 sell
Insider Net $
$1.2M
Social Sentiment
50° Neutral
SEC Reports
9
Press Releases
1
Price chart 30d -23.6%
Daily candles (open–high–low–close) with volume. Green = up day, red = down day.
No data for this timeframe.
Vol
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Sep 25, 2026 short_volume
Sep 10, 2026 SEC Short Volume: XRAY — 55.1% short (1.0M / 1.9M)
Short: 1,022,736 | Exempt: 5,506 | TRF Vol: 1,855,344 | Short Ratio: 55.1% | Off-exchange volume (da
A mixed institutional cluster for DENTSPLY SIRONA (XRAY) in 2026-Q2 shows $61.2M in net buying from 42 buyers (led by ac
INST-CLUSTER — Impact 5/10
Aug 10, 2026 Insider
Fortson John C. was granted 24,014 shares
EVP & CFO
Aug 10, 2026 Insider
Fortson John C. was granted 104,200 shares
EVP & CFO
Aug 7, 2026 Insider
Frohning Andrea L. surrendered for taxes 802 shares
SVP, CHRO @ $12.12 ($9.7K)
Jun 30, 2026 Inst.
BlackRock, Inc. — ADD
26,711,079 shares ($283.4M)
Jun 30, 2026 Inst.
Jun 16, 2026 SEC STATE STREET CORP — ADD
9,285,298 shares ($98.5M)
Five Dentsply Sirona directors made open-market purchases totaling ~$516K over a five-day window, representing just 0.02
CLUSTER — Impact 3/10
Analyst ratings buy % +9.4%
How Wall Street rates the stock today, and the latest firm-by-firm actions.
35% rate it Buy or better · 23 analysts
Recent analyst actions
| Date | Firm | Action | Rating | Firm rating |
|---|---|---|---|---|
| Sep 17, 2026 | BMO Capital | MAINTAIN | Market Perform | 53% |
| Aug 24, 2026 | Barclays | MAINTAIN | Underweight | 54% |
| Jul 29, 2026 | Piper Sandler | MAINTAIN | Neutral | 54% |
| Jul 9, 2026 | BMO Capital | INITIATE | Market Perform | 53% |
| Jun 4, 2026 | Barclays | MAINTAIN | Underweight | 54% |
| May 7, 2026 | UBS | MAINTAIN | Buy | 55% |
| May 6, 2026 | Mizuho | MAINTAIN | Neutral | 52% |
| Apr 15, 2026 | Citigroup | INITIATE | Sell | 55% |
Monthly consensus history
| Period | Str. Buy | Buy | Hold | Sell | Str. Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | 4 | 4 | 13 | 1 | 1 | 35% | |
| Aug 1, 2026 | 4 | 4 | 13 | 1 | 1 | 35% | |
| Jul 1, 2026 | 4 | 4 | 12 | 1 | 1 | 36% | |
| Jun 1, 2026 | 4 | 4 | 12 | 1 | 1 | 36% | |
| May 1, 2026 | 4 | 4 | 12 | 1 | 1 | 36% | |
| Apr 1, 2026 | 4 | 4 | 12 | 1 | 0 | 38% | |
| Mar 1, 2026 | 4 | 4 | 13 | 1 | 0 | 36% | |
| Feb 1, 2026 | 3 | 4 | 14 | 1 | 0 | 32% |
Price targets
Where 15 covering analysts think XRAY trades over the next 12 months.
$13.73 +59.2% upside Strong Buy
Current$8.63 Low$10.00 Median$14.00 High$17.00 15 analysts
$10.00$17.00
Analyst rating Hold· 2.7/5 as of Oct 2, 2026
Social media sentiment
Retail-investor mood aggregated across social media. 0° = very bearish, 100° = very bullish.
50°
Neutral
BearishNeutralBullish
Recent posts
Reports & filings
AI-scored summaries of recent SEC filings and press releases, with sentiment and impact.
9 SEC filing reports analyzed · 0 bullish, 1 bearish, 2 mixed, 6 neutral · avg impact 3.9/10.Plus 1 press releases.
MIXEDINST-CLUSTER5/10
A mixed institutional cluster for DENTSPLY SIRONA (XRAY) in 2026-Q2 shows $61.2M in net buying from
Sep 10, 2026
NEUTRALCLUSTER3/10
Five Dentsply Sirona directors made open-market purchases totaling ~$516K over a five-day window, re
Jun 16, 2026
NEUTRALCLUSTER3/10
Two directors purchased shares totaling ~$250K at ~$9.88, representing a trivial 0.0125% of market c
Jun 15, 2026
NEUTRAL8-K3/10
DENTSPLY SIRONA appointed John C. Fortson as EVP & CFO, effective July 20, 2026, replacing the prior
Jun 11, 2026
Upcoming & catalyst events
Scheduled dates plus disclosed catalysts — earnings, dividends, enforcement, FDA and clinical-trial events. Colored dot = impact.
Sep 25, 2026
short_volume
Short Volume: XRAY — 55.1% short (1.0M / 1.9M)
Short: 1,022,736 | Exempt: 5,506 | TRF Vol: 1,855,344 | Short Ratio: 55.1% | Off-exchange volume (dark pool + OTC)
Sep 24, 2026
short_volume
Short Volume: XRAY — 56.3% short (0.8M / 1.5M)
Short: 838,646 | Exempt: 6 | TRF Vol: 1,488,580 | Short Ratio: 56.3% | Off-exchange volume (dark pool + OTC)
Sep 23, 2026
short_volume
Short Volume: XRAY — 66.6% short (0.8M / 1.2M)
Short: 813,129 | Exempt: 0 | TRF Vol: 1,220,204 | Short Ratio: 66.6% | Off-exchange volume (dark pool + OTC)
Sep 22, 2026
short_volume
Short Volume: XRAY — 56.1% short (1.0M / 1.7M)
Short: 972,489 | Exempt: 0 | TRF Vol: 1,734,378 | Short Ratio: 56.1% | Off-exchange volume (dark pool + OTC)
Sep 18, 2026
short_volume
Short Volume: XRAY — 56.3% short (1.4M / 2.6M)
Short: 1,444,327 | Exempt: 68 | TRF Vol: 2,563,869 | Short Ratio: 56.3% | Off-exchange volume (dark pool + OTC)
Earnings estimates
Forecast earnings per share and revenue by period — and whether estimates are rising.
| Period | EPS Est. | Range | Growth | 30d Rev | Up/Dn | Revenue | # |
|---|---|---|---|---|---|---|---|
| Current Q | $0.31 | $0.26–$0.35 | -16.4% | -0.5% | 0↑ 16↓ | $0.9B | 15 |
| Next Q | $0.46 | $0.34–$0.54 | 69.8% | -0.2% | 11↑ 3↓ | $0.9B | 15 |
| Current FY | $1.50 | $1.28–$1.61 | -6.3% | -0.3% | 12↑ 5↓ | $3.6B | 17 |
| Next FY | $1.51 | $1.37–$1.65 | 0.6% | -0.6% | 5↑ 13↓ | $3.6B | 17 |
Current-quarter EPS estimate — revision history
| When | EPS estimate | Change vs now |
|---|---|---|
| Current | $0.310 | — |
| 7d ago | $0.311 | -0.002 |
| 30d ago | $0.311 | -0.002 |
| 60d ago | $0.372 | -0.062 |
| 90d ago | $0.369 | -0.060 |
Institutional ownership
Which big funds own XRAY (from quarterly 13F filings) and who is adding or trimming.
50 institutional holders with $1.7B total value (160,021,212 shares) as of 2026-Q2. Top holders: BlackRock,, FULLER, VANGUARD. Net buying activity: 35 institutions added/increased vs 15 reduced.
Top holders — 2026-Q2
| Fund | Shares | Value | % Tracked | Last move |
|---|---|---|---|---|
| BlackRock, Inc. | 26,711,079 | $283.4M | 16.7% | ADD +38.7% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 12,697,269 | $134.7M | 7.9% | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 11,779,851 | $125.0M | 7.4% | — |
| AQR CAPITAL MANAGEMENT LLC | 10,458,771 | $110.2M | 6.5% | — |
| STATE STREET CORP | 9,285,298 | $98.5M | 5.8% | ADD +28.2% |
| VANGUARD CAPITAL MANAGEMENT LLC | 9,047,628 | $96.0M | 5.7% | — |
| LAZARD ASSET MANAGEMENT LLC | 8,269,867 | $87.7M | 5.2% | — |
| ARIEL INVESTMENTS, LLC | 8,026,107 | $85.2M | 5.0% | ADD +25.7% |
| GEODE CAPITAL MANAGEMENT, LLC | 5,650,605 | $60.0M | 3.5% | ADD +47.8% |
| JUPITER ASSET MANAGEMENT LTD | 4,495,136 | $47.7M | 2.8% | DOUBLED +457.0% |
Recent position changes
| Fund | Action | Prev | Current | Change | Value |
|---|---|---|---|---|---|
| BlackRock, Inc. | ADD | 19,251,869 | 26,711,079 | +38.7% | $283.4M |
| STATE STREET CORP | ADD | 7,244,837 | 9,285,298 | +28.2% | $98.5M |
| ARIEL INVESTMENTS, LLC | ADD | 6,386,815 | 8,026,107 | +25.7% | $85.2M |
| GEODE CAPITAL MANAGEMENT, LLC | ADD | 3,823,637 | 5,650,605 | +47.8% | $60.0M |
| JUPITER ASSET MANAGEMENT LTD | DOUBLED | 806,965 | 4,495,136 | +457.0% | $47.7M |
| Allianz Asset Management GmbH | ADD | 2,946,184 | 3,823,808 | +29.8% | $40.6M |
| Neuberger Berman Group LLC | ADD | 1,900,712 | 2,937,567 | +54.6% | $31.2M |
| NORTHERN TRUST CORP | ADD | 1,754,884 | 2,590,933 | +47.6% | $27.5M |
| GOLDMAN SACHS GROUP INC | DOUBLED | 660,053 | 1,843,586 | +179.3% | $19.6M |
| COMMONWEALTH EQUITY SERVICES, LLC | ADD | 1,263,901 | 1,586,834 | +25.6% | $16.8M |
Insider activity
Buying and selling by company executives and directors (SEC Form 4).
17 insiders, 50 transactions. Net $1.2M — $1.2M bought, $0.00 sold.
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 10, 2026 | Fortson John C. | EVP & CFO | AWARD | 24,014 | — | — |
| Aug 10, 2026 | Fortson John C. | EVP & CFO | AWARD | 104,200 | — | — |
| Aug 7, 2026 | Frohning Andrea L. | SVP, CHRO | TAX W/H | 802 | $12.12 | $9.7K |
| Jun 30, 2026 | MAZELSKY JONATHAN JAY | Director | AWARD | 2,841.83 | $10.56 | $30.0K |
| Jun 15, 2026 | Gladden Brian T | Director | BUY | 9,985.022 | $10.02 | $100.0K |
| Jun 15, 2026 | HOSEIN CLYDE | Director | BUY | 6,500 | $9.99 | $64.9K |
| Jun 12, 2026 | MAZELSKY JONATHAN JAY | Director | AWARD | 10,000 | $10.14 | $101.4K |
| Jun 12, 2026 | MCKEON BRIAN P | Director | BUY | 10,000 | $10.12 | $101.2K |
| Jun 12, 2026 | MAZELSKY JONATHAN JAY | Director | BUY | 10,000 | $10.14 | $101.4K |
| Jun 11, 2026 | Barber Michael J | Director | BUY | 15,175 | $9.89 | $150.0K |
Short interest & halts
FINRA semi-monthly short positions, Reg SHO threshold status, and recent trading halts for XRAY.
Shares short
24,588,198
Settlement Sep 15, 2026
Change vs prior
+11.3%
Semi-monthly cycle
Days to cover
6.9
At avg daily volume
Of shares outstanding
≈12.3%
Estimate — not % of float
All XRAY filing & press-release reports (10)
- INST-CLUSTER reportSep 10, 2026
- CLUSTER reportJun 16, 2026
- CLUSTER reportJun 15, 2026
- 8-K reportJun 11, 2026
- 8-K reportMay 5, 2026
- PRESS-RELEASE reportMay 5, 2026
- PRESS-RELEASE reportApr 22, 2026
- CLUSTER reportMar 9, 2026
- PRESS-RELEASE reportMar 9, 2026
- 8-K reportFeb 24, 2026